Alkermes (ALKS) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Jefferies on Alkermes (ALKS) Earnings: 'Solid Q3 + FY guide raise'
October 28, 2025 1:16 PM EDTJefferies analyst Akash Tewari reiterated a Buy rating and $56.00 price target on Alkermes (NASDAQ: ALKS).
The analyst comments "ALKS reported a solid Q - revs beat at $394M vs $353M cons & adj EPS was $0.72 vs $0.43 cons. All products beat... More
